North America Recombinant Cell Culture Supplements Market to Grow with a CAGR of 9.44% through 2028
Increase in the Demand
for Biopharmaceuticals and increase in the aging population is expected to
drive the North America Recombinant Cell Culture Supplements Market growth in
the forecast period, 2024-2028.
According to
TechSci Research report, “North America Recombinant Cell Culture Supplements Market – Industry Size, Share, Trends, Competition Forecast &
Opportunities, 2028”, the North America Recombinant Cell Culture
Supplements Market stood at USD 193.31 billion in 2022 and is anticipated to
grow with a CAGR of 9.44% in the forecast period, 2024-2028. The awareness
among individuals regarding Recombinant Cell Culture Supplements has led to
favorable market conditions for the North America Recombinant Cell Culture
Supplements market. Several factors contribute to the growth of various Recombinant
Cell Culture Supplements products.
The North
America Recombinant Cell Culture Supplements Market is significantly driven by
the increasing demand for biopharmaceuticals, which encompass monoclonal
antibodies, vaccines, and gene therapies. These biopharmaceuticals are gaining
prominence due to their proven effectiveness in treating a wide range of
diseases. This heightened demand is primarily fueled by factors such as an
aging population, the growing prevalence of chronic illnesses, and the
escalating need for innovative healthcare solutions. As biopharmaceutical
production heavily relies on recombinant cell culture supplements to facilitate
cell growth and protein expression, the market for these supplements is
experiencing substantial growth. Biopharmaceutical companies and contract
manufacturing organizations (CMOs) are increasingly dependent on the consistent
quality of culture supplements to enhance and streamline their production
processes, thereby contributing significantly to the market's expansion.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "North America Recombinant Cell Culture Supplements Market.”
There is an
increasing demand for cell culture supplements that are free from
animal-derived components and precisely defined chemically. This trend arises
from concerns related to the potential transmission of animal-borne diseases,
batch-to-batch variability, and the need for greater control and
reproducibility in cell culture processes, which will further fuel market
growth. Also, to meet the specific requirements of biopharmaceutical
production, manufacturers of cell culture supplements are innovating and
customizing their products. This includes developing specialized media and
supplements optimized for the growth and expression of specific cell lines used
in biopharmaceutical manufacturing.
In June 2023,
Merck KGaA announced the expansion of its facility in Lenexa, Kansas, USA. The
expansion will add 9,100 square meters of lab space and is expected to create
100 new jobs. The expanded facility will be used to support Merck KGaA's
growing life science business in North America.
The growing
demand for biopharmaceuticals necessitates larger-scale production, often
involving mammalian cell culture systems. Recombinant cell culture supplements,
such as growth factors, media, and serum alternatives, are vital for supporting
cell growth and protein expression during biopharmaceutical production.
In today's
fast-paced world, In the race to develop new drugs and therapies, time is a
critical factor. Recombinant cell culture supplements play a pivotal role in
accelerating the production of therapeutic proteins, monoclonal antibodies,
vaccines, and gene therapies for biopharmaceutical companies. This acceleration
translates into faster drug development, more efficient clinical trials, and,
ultimately, swifter access to life-saving treatments for patients. The
utilization of top-notch cell culture supplements is instrumental in optimizing
cell growth and protein expression, leading to increased yields and shortened
production cycles. This heightened productivity empowers companies to promptly
address market demands with greater efficiency. In the realm of scientific
exploration, where rapid progress is essential, researchers depend on
recombinant cell culture supplements for cultivating cells and conducting
experiments. These supplements create the essential environment for studying
disease mechanisms, crafting novel therapies, and achieving groundbreaking
discoveries across various scientific and medical disciplines. Furthermore,
recombinant cell culture supplements offer a valuable advantage by being
customizable to align with specific cell lines, applications, and research
objectives. This adaptability equips both researchers and biopharmaceutical
companies with the agility needed to swiftly respond to evolving project
requirements and shifting market dynamics. In a fiercely competitive landscape,
ensuring product quality stands as a paramount consideration. High-caliber cell
culture supplements undergo rigorous quality control measures, guaranteeing
unwavering consistency and reliability. This consistent quality assurance is
indispensable for achieving reproducible results and maintaining regulatory
compliance throughout the drug development and manufacturing processes.
The growing
awareness among consumers regarding health and wellness has shifted the focus
towards the ideology of "prevention is better than cure." As a
result, more individuals are relying on nutraceuticals, functional foods, and
dietary and Recombinant Cell Culture Supplements to lead a healthy and
disease-free life.
In recent times,
Recombinant cell culture supplements are integral in the production of
biopharmaceuticals such as monoclonal antibodies, vaccines, gene therapies, and
recombinant proteins. They provide the necessary nutrients, growth factors, and
culture media to support the growth and expression of cells used in
biomanufacturing. The production of vaccines, especially viral vaccines and
subunit vaccines, relies on cell culture techniques. Recombinant supplements
are used to cultivate host cells and produce viral antigens or subunits for
vaccine formulation. The demand for mAbs in therapeutic applications is
growing. Recombinant supplements are essential for optimizing cell lines used
in mAb production, resulting in higher yields and improved product quality.
However, the High Cost of Production of complex biotechnological processes may
hinder market growth. Moreover, challenges related to Regulatory Hurdles and
Compliance and Supply Chain Vulnerabilities may pose obstacles to the Recombinant
Cell Culture Supplements market in the near future.
The North
America Recombinant Cell Culture Supplements Market is segmented into product, application,
expression system, end-user, regional distribution, and company.
Based on its product,
the Recombinant growth factors segment emerged as the dominant player in the
North America market for Recombinant Cell Culture Supplements in 2022. This segment
plays a pivotal role in supporting cell growth, proliferation, and protein
expression, making it a critical component in various biopharmaceutical and
biotechnology applications. Consequently, Recombinant growth factors, such as
various types of cytokines and growth-promoting proteins, are indispensable for
promoting cell proliferation and ensuring cell viability in vitro. These
factors mimic the natural cellular environment, facilitating the growth of
mammalian cells, including those used in the production of biopharmaceuticals. Growth
factors play a vital role in enhancing the expression of recombinant proteins
in cell cultures. They stimulate cells to produce more proteins, including
therapeutic proteins and antibodies, which are crucial for the biopharmaceutical
industry.
Based on region,
United States segment is expected to grow during the forecast
period. The United States is the largest economy in North America
and a North America leader in the biopharmaceutical industry. Its economic
strength, robust healthcare infrastructure, and significant investments in
healthcare and life sciences contribute to its dominance in the market. The
U.S. is home to a large number of biotechnology and pharmaceutical companies,
including major players in the biopharmaceutical sector. These companies drive
the demand for cell culture supplements due to their extensive biomanufacturing
operations. The U.S. hosts numerous research institutions, universities, and
academic centers engaged in biopharmaceutical research and development. These
organizations require cell culture supplements for their studies and often
collaborate with industry players. The U.S. has a well-established and rigorous
regulatory framework for biopharmaceuticals. Compliance with regulatory standards,
such as Good Manufacturing Practices (GMP), necessitates the use of
high-quality cell culture supplements.
The Canada
market is poised to be the fastest-growing market, offering lucrative growth
opportunities for Recombinant Cell Culture Supplements players during the
forecast period. Factors such as Canada's biopharmaceutical sector is
experiencing growth, with a rising number of biotech startups, research
collaborations, and investments in biomanufacturing facilities. The Canadian
government offers incentives, grants, and support for biopharmaceutical
research and development. These initiatives encourage innovation and contribute
to market growth. Canada has a well-educated and skilled workforce in the life
sciences sector, attracting international companies and fostering local
biopharmaceutical growth. Canada's strategic location provides easy access to
both North American and international markets, making it an attractive
destination for biopharmaceutical manufacturing. Canada often collaborates with
U.S. biotech firms and research institutions, further boosting its
biopharmaceutical activities.
Major companies
operating in North America Recombinant Cell Culture Supplements Market
are:
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Corning Incorporated
- FUJIFILM Irvine Scientific, Inc.
- Lonza Group AG
- Novus Biologicals, LLC
- BBI Solutions OEM Limited
- Gemini Bioproducts, LLC
Download Free Sample Report
Customers can
also request for 10% free customization on this report.
“The advances in
personalized medicine and increasing Prevalence of Chronic Diseases are key
drivers of the Recombinant Cell Culture Supplements market. In recent years, The
demographic shift toward an aging population increases the prevalence of
chronic diseases and age-related conditions. Biopharmaceuticals are often used
to address these health challenges, driving the demand for cell culture
supplements. Moreover, the growing consumer emphasis on preventative healthcare
products has enhanced production and marketing efforts. To meet the demands of
the market, manufacturers are increasingly incorporating cutting-edge
technologies with high production efficiency. Rising consumer acceptance and
continuous product innovation will further ensure the growth of the Recombinant
Cell Culture Supplements and supplements market in the coming years.,” said Mr.
Karan Chechi, Research Director with TechSci Research, a research-based
management consulting firm.
“North America
Recombinant Cell Culture Supplements Market Segmented By Product (Recombinant
Albumin, Recombinant Insulin, Recombinant Epidermal Growth Factors, Recombinant
Transferrin, Recombinant Trypsin, Others), By Application (Regenerative
Medicine & Bio-Production), By Expression System (Mammalian Expression
System, E.Coli Expression System, Yeast Expression System, Others), By End-User
(Academic & Research Institutions, Biotechnology & Pharmaceutical
Companies, Others), By Country, Competition, Forecast & Opportunities,
2018-2028”, has evaluated the future growth potential of North
America Recombinant Cell Culture Supplements Market and provides statistics
& information on market size, structure and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in North America Recombinant Cell Culture Supplements Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com